271 related articles for article (PubMed ID: 31122991)
1. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.
Lírio J; Giraldo PC; Amaral RL; Sarmento ACA; Costa APF; Gonçalves AK
BMJ Open; 2019 May; 9(5):e027489. PubMed ID: 31122991
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Treatment for recurrent vulvovaginal candidiasis (thrush).
Cooke G; Watson C; Deckx L; Pirotta M; Smith J; van Driel ML
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD009151. PubMed ID: 35005777
[TBL] [Abstract][Full Text] [Related]
4. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Ray A; Ray S; George AT; Swaminathan N
Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
[TBL] [Abstract][Full Text] [Related]
5. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis.
Rosa MI; Silva BR; Pires PS; Silva FR; Silva NC; Silva FR; Souza SL; Madeira K; Panatto AP; Medeiros LR
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):132-6. PubMed ID: 23280281
[TBL] [Abstract][Full Text] [Related]
6. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Fan S; Liu X; Wu C; Xu L; Li J
Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
[TBL] [Abstract][Full Text] [Related]
7. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Nurbhai M; Grimshaw J; Watson M; Bond C; Mollison J; Ludbrook A
Cochrane Database Syst Rev; 2007 Oct; (4):CD002845. PubMed ID: 17943774
[TBL] [Abstract][Full Text] [Related]
8. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Watson MC; Grimshaw JM; Bond CM; Mollison J; Ludbrook A
Cochrane Database Syst Rev; 2001; (4):CD002845. PubMed ID: 11687165
[TBL] [Abstract][Full Text] [Related]
9. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Watson MC; Grimshaw JM; Bond CM; Mollison J; Ludbrook A
Cochrane Database Syst Rev; 2001; (1):CD002845. PubMed ID: 11279767
[TBL] [Abstract][Full Text] [Related]
10. Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC).
Vandecruys P; Baldewijns S; Sillen M; Van Genechten W; Van Dijck P
Expert Rev Anti Infect Ther; 2023; 21(8):799-812. PubMed ID: 37449774
[TBL] [Abstract][Full Text] [Related]
11. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.
Yano J; Sobel JD; Nyirjesy P; Sobel R; Williams VL; Yu Q; Noverr MC; Fidel PL
BMC Womens Health; 2019 Mar; 19(1):48. PubMed ID: 30925872
[TBL] [Abstract][Full Text] [Related]
12. Recurrent vulvovaginal candidiasis.
Sobel JD
Am J Obstet Gynecol; 2016 Jan; 214(1):15-21. PubMed ID: 26164695
[TBL] [Abstract][Full Text] [Related]
13. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
Chew SY; Than LT
Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
[TBL] [Abstract][Full Text] [Related]
14. Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review.
Bradfield Strydom M; Khan S; Walpola RL; Ware RS; Tiralongo E
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37171871
[TBL] [Abstract][Full Text] [Related]
15. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for vulvovaginal candidiasis in non-pregnant women.
Xie HY; Feng D; Wei DM; Mei L; Chen H; Wang X; Fang F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD010496. PubMed ID: 29168557
[TBL] [Abstract][Full Text] [Related]
17. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
van Schalkwyk J; Yudin MH;
J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
[TBL] [Abstract][Full Text] [Related]
18. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.
Bond CM; Watson MC;
Pharm World Sci; 2003 Aug; 25(4):177-81. PubMed ID: 12964498
[TBL] [Abstract][Full Text] [Related]
19. Recurrent vulvovaginal candidiasis.
Blostein F; Levin-Sparenberg E; Wagner J; Foxman B
Ann Epidemiol; 2017 Sep; 27(9):575-582.e3. PubMed ID: 28927765
[TBL] [Abstract][Full Text] [Related]
20. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Denison HJ; Worswick J; Bond CM; Grimshaw JM; Mayhew A; Gnani Ramadoss S; Robertson C; Schaafsma ME; Watson MC
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD002845. PubMed ID: 32845024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
